Skip to main content

Table 2 Factors affecting time to initiate ART

From: Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi

Factor

Unadjusted analysis

Adjusted analysis

Hazard ratio

95 % CI

p-value

Hazard ratio

95 % CI

p-value

Sex

  

0.012

  

0.930

Male

1 (ref)

  

1 (ref)

  

Female

0.80

0.67–0.95

 

0.99

0.83–1.19

 

Age at enrolment

  

0.259

  

0.996

15–34

1 (ref)

  

1 (ref)

  

≥35

1.11

0.93–1.32

 

1.00

0.83–1.20

 

CD4 count (cells/μL) at enrolment

  

<0.001

  

<0.001

≤250

1 (ref)

  

1 (ref)

  

251–350

0.36

0.28–0.47

 

0.35

0.27–0.46

 

351–500

0.18

0.13–0.25

 

0.17

0.13–0.24

 

>500

0.12

0.09–0.16

 

0.12

0.09–0.17

 

Missing

0.71

0.40–1.27

 

0.74

0.41–1.33

 

Year of enrolment

  

0.002

  

<0.001

2008

1 (ref)

  

1 (ref)

  

2009

0.69

0.56–0.86

 

0.62

0.49–0.77

 

2010

0.89

0.71–1.11

 

0.74

0.59–0.93

 

2011

0.66

0.48–0.91

 

0.60

0.44–0.83

 

Route of HIV testing

  

<0.001

  

0.009

CRH

1 (ref)

  

1 (ref)

  

HIV serosurvey

0.71

0.59–0.85

 

0.75

0.62–0.91

 

Missing

1.04

0.77–1.41

 

1.01

0.74–1.38

Â